Sep 30, 2021

Immunome Q3 2021 Earnings Report

EPS
-$0.65
Previous year: -$7.52
-91.4%
Cash and Equivalents
$56.2M
Previous year: $6.74M
+734.0%
Free Cash Flow
-$4.17M
Total Assets
$62.6M
Previous year: $12M
+422.1%

Immunome

Immunome